» Articles » PMID: 12447690

Over Expression of Endoglin in Human Prostate Cancer Suppresses Cell Detachment, Migration and Invasion

Overview
Journal Oncogene
Date 2002 Nov 26
PMID 12447690
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

The regulation of cell adhesion and motility in human prostate is not well understood. We have previously shown that the endoglin gene is differently expressed during changes in prostate cell adhesion. Endoglin is a transmembrane transforming growth factor beta binding protein typically expressed by endothelial cells. In this report we demonstrate that endoglin over expression increases prostate cell attachment, while decreasing migration and invasion. Engineered decreases in endoglin expression have opposite effects. While endoglin exerted only relatively small effects upon cell adhesion, large effects upon cell migration and invasion were observed. Endoglin was shown to localize to focal adhesion plaques, consistent with its role in regulating cell adhesion and motility. Loss of endoglin expression in cancer, as compared to normal prostate, was seen in human prostate cell lines. Suppression of endoglin expression in a panel of normal human prostate cell lines led to cell detachment. Endoglin is identified as a regulator of cell adhesion, motility and invasion in human prostate. Loss of endoglin expression appears to be associated with prostate cancer progression, at least in vitro.

Citing Articles

Endoglin and squamous cell carcinomas.

Hakuno S, Janson S, Trietsch M, de Graaf M, de Jonge-Muller E, Crobach S Front Med (Lausanne). 2023; 10:1112573.

PMID: 37396898 PMC: 10313935. DOI: 10.3389/fmed.2023.1112573.


Tumoral CD105 promotes immunosuppression, metastasis, and angiogenesis in renal cell carcinoma.

Oladejo M, Nguyen H, Seah H, Datta A, Wood L Cancer Immunol Immunother. 2022; 72(6):1633-1646.

PMID: 36586013 PMC: 10991561. DOI: 10.1007/s00262-022-03356-5.


Endoglin in the Spotlight to Treat Cancer.

Gonzalez Munoz T, Amaral A, Puerto-Camacho P, Peinado H, de Alava E Int J Mol Sci. 2021; 22(6).

PMID: 33804796 PMC: 8003971. DOI: 10.3390/ijms22063186.


Hot and Cold Tumors: Is Endoglin (CD105) a Potential Target for Vessel Normalization?.

Ollauri-Ibanez C, Ayuso-Inigo B, Pericacho M Cancers (Basel). 2021; 13(7).

PMID: 33800564 PMC: 8038031. DOI: 10.3390/cancers13071552.


TGF-β superfamily co-receptors in cancer.

Pawlak J, Blobe G Dev Dyn. 2021; 251(1):137-163.

PMID: 33797167 PMC: 8484463. DOI: 10.1002/dvdy.338.